v3.26.1
BUSINESS ACQUISITIONS (Tables)
 6 Months Ended
Jun. 30, 2026
Business Combination [Abstract]  
Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] The valuation of acquired assets and assumed liabilities included the following:
Empire City Laboratories, Inc.Parkview Health Systems, Inc.Other Acquisitions Closed During the
Six Months Ended
June 30, 2026		Measurement Period AdjustmentsAmounts Acquired During the
Six Months Ended June 30, 2026
Cash and cash equivalents$— $— $0.4 $— $0.4 
Accounts receivable— — 3.6 — 3.6 
Property, plant, and equipment— — 2.8 — 2.8 
Goodwill117.5 77.5 68.1 (1.0)262.1 
Intangible assets132.5 87.5 68.2 (13.1)275.1 
Total assets acquired250.0 165.0 143.1 (14.1)544.0 
Accounts payable— — 2.5 — 2.5 
Accrued expenses and other— — 1.7 — 1.7 
Notes payable— — 0.9 — 0.9 
Deferred tax liability— — 7.5 — 7.5 
Lease liabilities— — 2.4 — 2.4 
Total liabilities acquired— — 15.0 — 15.0 
Net assets acquired250.0 165.0 128.1 (14.1)529.0 
Contingent consideration(85.0)— (4.8)14.1 (75.7)
2025 escrow payments— (5.0)(20.0)— (25.0)
Cash paid for acquisitions$165.0 $160.0 $103.3 $— $428.3 
Intangible Asset, Finite-Lived, Acquired
Intangible assets recognized from business acquisitions that closed during the six months ended June 30, 2026, including any related measurement period adjustments, and their weighted-average amortization periods were as follows:
Amount
Weighted-average Amortization Period
(in Years)
Customer relationships$239.3 15.0
Non-compete agreements48.9 5.0
   Total
$288.2 
Business Combination, Pro Forma Information [Table Text Block]
If the aggregate of the Company’s 2026 and 2025 acquisitions, that were accounted for as business combinations, had been completed at January 1, 2025, the Company’s pro forma results would have been as follows:
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Revenues$3,734.1 $3,582.7 $7,296.3 $7,004.9 
Net earnings attributable to LHI$299.8 $245.4 $584.7 $472.4